| | SGRQ total score | symptom score | activity score | impact score |
---|
Total cell count†
| B (95% CI) | -1.7 (-8.0 to 4.6) | -4.6 (-12 to 3.4) | -0.74 (-9.2 to 7.7) | -1.1 (-7.3 to 5.1) |
% Neutrophils | B (95% CI) | -0.17 (-0.36 to 0.02) | -0.20 (-0.44 to 0.04) | -0.24 (-0.49 to 0.02)‡‡
| -0.11 (-0.30 to 0.08) |
% Macrophages | B (95% CI) | 0.22 (<0.01 to 0.43)* | 0.28 (0.01 to 0.56)* | 0.28 (-0.01 to 0.56)‡
| 0.15 (-0.07 to 0.36) |
% Eosinophils# | B (95% CI) | 0.22 (-4.0–4.5) | -0.73 (-6.13–4.67) | 2.42 (-3.27–8.10) | -0.61 (-4.80–3.58) |
- The univariate association between SGRQ scores (dependent) and sputum cell counts (independent) was expressed by regression coefficient B with corresponding 95% confidence intervals (95% CI). The regression coefficient B represents the strength of the association. Our results show that an increase in sputum macrophages of 1% is associated with an increase of the mean total score of 0.22 point, indicating that an increase in sputum macrophages of 20% is associated with an increase of the mean total score of 4.4 points, which exceeds the clinically relevant threshold of four units in SGRQ scores. †Total cell count was logtransformated; # % eosinophils were transformed using the square root. *p ≤ 0.05, ‡p = 0.061, ‡‡p = 0.068.